Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 9/2008

01-09-2008

Prevalence of Helicobacter pylori Seropositivity Among Patients Undergoing Bariatric Surgery: A Preliminary Study

Authors: Tolga Erim, Marcia R. Cruz-Correa, Samuel Szomstein, Evelio Velis, Raul Rosenthal

Published in: World Journal of Surgery | Issue 9/2008

Login to get access

Abstract

Background

The objective of this study was to compare the prevalence of Helicobacter pylori (HP) seropositivity in patients undergoing bariatric surgery with that of the general population.

Methods

H. pylori serologies, tested by ELISA, were collected on 240 morbidly obese patients seen at the Cleveland Clinic Florida and on 2444 randomly selected patients seen at the Cleveland Clinic Health System from 2003–2005.

Results

H. pylori prevalence was 61.3% in the bariatric surgery group versus 48.2% in the general population control group (p < 0.001). Bariatric patients had a 1.7-fold increased likelihood of having HP when compared with controls (95% CI = 1.3–2.2). Age over 35 years was an independent risk factor for HP seropositivity (p < 0.01) in both the bariatric and control groups. There was no association found between body mass index and seropositivity within the bariatric group. There was no significant association between seropositivity and gender (p = 0.776). However, there was a significant association between seropositivity and race (p < 0.01). African-Americans had four times more (OR = 4.05) probability of having HP seropositivity than Caucasians (p < 0.01). Hispanics had almost three times (OR = 2.6) more probability of having HP seropositivity than Caucasians (p < 0.01).

Conclusion

The prevalence of HP seropositivity among bariatric patients is significantly higher than the general population control group.
Literature
1.
2.
Flegal KM, Carroll MD, Ogden CL et al (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727PubMedCrossRef
3.
Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: A systematic review and meta-analysis. JAMA 292(14):1724–1737PubMedCrossRef
4.
Marshall BJ, Windsor HM (2005) The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am 89:313–344PubMedCrossRef
5.
International Agency for Research on Cancer (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:177–241
6.
Ramaswamy A, Lin E, Ramshaw BJ et al (2004) Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg 139:1094–1096PubMedCrossRef
7.
Schirmer B, Erenoglu C, Miller A (2002) Flexible endoscopy in the management of patient undergoing Roux-en-Y gastric bypass. Obes Surg 12:634–638PubMedCrossRef
8.
Papasavas PK, Gagné DJ, Donnelly PE et al (2008) Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 4(3):383–388PubMedCrossRef
9.
Renshaw AA, Rabaza JR, Gonzalez AM et al (2001) Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg 11(3):281–283PubMedCrossRef
10.
Fontana L, Eagon JC, Colonna M et al (2007) Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res 10(1):41–46PubMedCrossRef
11.
O’Rourke RW, Kay T, Lyle EA et al (2006) Alterations in peripheral blood lymphocyte cytokine expression in obesity. Clin Exp Immunol 146(1):39–46PubMedCrossRef
12.
Amar S, Zhou Q, Shaik-Dasthagirisaheb Y et al (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 104(51):20466–20471PubMedCrossRef
13.
Smith AG, Sheridan PA, Harp JB et al (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 137:1236–1243PubMed
14.
Wu MS, Lee WJ, Wang HH et al (2005) A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 165(13):1552–1555PubMedCrossRef
15.
Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM et al (1997) Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol 223:28–34
16.
Ohkuma K, Okada M, Murayama H et al (2000) Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 15:1105–1112PubMedCrossRef
17.
Asaka M, Sugiyama T, Nobuta A et al (2001) Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6:294–299PubMedCrossRef
18.
Malfertheiner P, Megraud F, O’Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56(6):772–781PubMedCrossRef
19.
Safatle-Ribeiro AV, Kuga R, Iriya K, Ribeiro et al (2007) What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 11(2):133–137PubMedCrossRef
20.
Kihira K, Satoh K, Saifuku K et al (1996) Endoscopic topical therapy for the treatment of Helicobacter pylori infection. J Gastroenterol 31(Suppl 9):66–68PubMed
21.
Satoh K (1996) Treatment of Helicobacter pylori infection by topical administration of antimicrobial agents. Scand J Gastroenterol Suppl 214:56; discussion 57–60PubMedCrossRef
22.
Nwokolo CU, Mistry P, Pounder RE (1990) The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Aliment Pharmacol Ther 4:163–169PubMedCrossRef
23.
Whitehead MW, Phillips RH, Sieniawska CE et al (2000) Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia. Helicobacter 5:169–175PubMedCrossRef
24.
Moshkowitz M, Konikoff FM, Peled Y et al (1995) High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 36:845–847 PubMedCrossRef
25.
Sheu BS, Yang HB, Su IJ et al (1996) Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc 44:683–688PubMedCrossRef
26.
Megraud F, Brassens Rabbe MP, Denis F et al (1989) Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 27:1870–1873PubMed
27.
Woodward M, Morrison C, McColl K (2000) An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 53:175–181PubMedCrossRef
28.
Go MF (2002) Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16(Suppl 1):3–15PubMedCrossRef
Metadata
Title
Prevalence of Helicobacter pylori Seropositivity Among Patients Undergoing Bariatric Surgery: A Preliminary Study
Authors
Tolga Erim
Marcia R. Cruz-Correa
Samuel Szomstein
Evelio Velis
Raul Rosenthal
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 9/2008
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9608-7

Other articles of this Issue 9/2008

World Journal of Surgery 9/2008 Go to the issue

OriginalPaper

Anal Sphincter Asymmetry in Anal Incontinence After Restorative Proctectomy for Rectal Cancer

Letter

Neurofuzzy is Useful Aid in Diagnosing Acute Appendicitis

OriginalPaper

Esophageal and Gastric Cardia Cancers on 4238 Chinese Patients Residing in Municipal and Rural Regions: A Histopathological Comparison During 24-Year Period

ReviewPaper

The Hybrid SPECT/CT as an Additional Lymphatic Mapping Tool in Patients with Breast Cancer

OriginalPaper

Osteopontin Expression in Squamous Cell Cancer of the Esophagus

OriginalPaper

The Use of Polydimethylsiloxane for Injection Laryngoplasty